Article

Reactogenicity of COVID-19 vaccine in hemodialysis patients: a single-center retrospective study

2021-11-24

Abstract excerpt

<h4>Introduction</h4> Some hemodialysis patients are reluctant to COVID-19 for the development of adverse events (AEs). The aim of this study was to verify the safety of mRNA-1273 vaccine in hemodialysis patients. <h4>Methods</h4> We conducted a retrospective analysis of in-center hemodialysis patients who underwent mRNA-1273 vaccine from March 1 st to April 30 th , 2021. All AEs occurring after the first and the...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 198915b6-4516-5df6-8a94-39f71b284074
DOI: 10.1101/2021.11.21.21266561

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Reactogenicity of COVID-19 vaccine in hemodialysis patients: a single-center retrospective studyDOI 10.1101/2021.11.21.21266561Read

COVID-19 vaccination trends and side effects among Egyptian hemodialysis patients: a multicenter survey studySemantic proximity Read

Justification, safety, and efficacy of a third dose of mRNA vaccine in maintenance hemodialysis patients: a prospective observational studySemantic proximity Read

A systematic review assessing the effectiveness of COVID-19 mRNA vaccines in chronic kidney disease (CKD) individualsSemantic proximity Read

Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on hemodialysisSemantic proximity Read

Immune response to the mRNA COVID-19 vaccine in hemodialysis patients: cohort studySemantic proximity Read

A Malaysian Study on COVID-19 (SARS-CoV-2) Vaccination Immune Response in Haemodialysis patients: A prospective, multicenter, cohort studySemantic proximity Read

mRNA-COVID19 vaccination can be considered safe and tolerable for frail patientsSemantic proximity Read

Humoral Response to BNT162b2 mRNA Covid19 Vaccine in Peritoneal and Hemodialysis Patients: a Comparative StudySemantic proximity Read

Prevalence and risk factors of adverse effects after the first COVID-19 booster dose: evidence from GreeceSemantic proximity Read

Review on different COVID-19 vaccines approved for Emergency Use Listing by WHO until 11 July 2022: characterization, pharmacological properties, mechanism of action and adverse events.Semantic proximity Read

Influenza Vaccine Immunogenicity in Hemodialysis PatientsSemantic proximity Read

Incidence and management of the main adverse effects reported after COVID-19 vaccinationSemantic proximity Read